These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3906479)

  • 1. [Adjuvant chemotherapy in primary radically operated ovarian cancer].
    Illiger HJ; del Valle F; Mühlenstedt D
    Onkologie; 1985 Oct; 8(5):316, 321-3. PubMed ID: 3906479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant chemotherapy in patients operated on for early ovarian carcinoma].
    Trimbos JB; van der Burg ME
    Ned Tijdschr Geneeskd; 2004 May; 148(18):874-8. PubMed ID: 15152388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug therapy of ovarian carcinoma].
    Dittrich C
    Wien Med Wochenschr; 1996; 146(1-2):23-34. PubMed ID: 8835492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant ovarian germ cell tumours: a trial of 36 cases].
    Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
    Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current aspects of adjuvant therapy of early stage ovarian cancer.
    McGuire WP
    Zentralbl Gynakol; 1998; 120(3):93-7. PubMed ID: 9556898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
    Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
    Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy and prognostic significance of the size of the remaining tumor in ovarian cancer].
    Petru E; Lahousen M; Pickel H; Stettner H
    Gynakol Rundsch; 1989; 29 Suppl 2():413-4. PubMed ID: 2613067
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].
    du Bois A; Lück HJ; Meerpohl HG
    Zentralbl Gynakol; 1997; 119(7):299-323. PubMed ID: 9340970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Initial treatment for ovarian cancer].
    Suzuki M; Fujiwara H; Takei Y
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):224-9. PubMed ID: 19263611
    [No Abstract]   [Full Text] [Related]  

  • 12. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the management of women with ovarian cancer.
    Eltabbakh GH
    Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical therapy of ovarian carcinoma].
    Sevelda P
    Wien Med Wochenschr; 1996; 146(1-2):18-22. PubMed ID: 8835491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant chemotherapy of cancer of the ovary].
    Cappelaere P; Horner-Vallet D; Demaille A
    Bull Cancer; 1984; 71(4):363-9. PubMed ID: 6498348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is there a standard therapy in advanced ovarian carcinoma?].
    Köchli OR
    Praxis (Bern 1994); 1999 Jan; 88(4):123-5. PubMed ID: 10067114
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ovarian cancer from the standpoint of medical oncology].
    Kato Y; Katsumata N
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1017-21. PubMed ID: 17637538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of epithelial ovarian cancer: a review of the literature.
    Dupont NC; Berman ML
    Minerva Ginecol; 2004 Dec; 56(6):547-56. PubMed ID: 15729207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy as primary therapy in non-radically operated ovarian cancer].
    Brunner KW; Goldhirsch A; Greiner R
    Onkologie; 1985 Dec; 8(6):347-55. PubMed ID: 2419812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990.
    Venesmaa P
    Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.